Insider · CIK 0001672718
Vincent O'Neill
Files at BTAIQ (BioXcel Therapeutics, Inc.). First filing Dec 17, 2024, latest Dec 17, 2024.
In brief
Vincent O'Neill files SEC Form 4 as officer at BTAIQ (BioXcel Therapeutics, Inc.). Since Dec 17, 2024, Vincent O'Neill has reported 0 open-market buys worth $0 and 1 open-market sell worth $58, the latest filed on Dec 17, 2024.
A track record needs three past buys with six months of prices behind them; Vincent O'Neill has 0, so none is measured yet.
The newest scored trade: sold $58 of BTAIQ on Dec 16, 2024, filed Dec 17, 2024, scored 0 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BTAIQ: BioXcel Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | BioXcel Therapeutics, Inc. | $58 165 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 16, 2024 | BTAIQ BioXcel Therapeutics, Inc. | 165 0.00% of outstanding | $58 | Dec 16, 2024 | $3,151 |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | BTAIQ BioXcel Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,875 | $0.00 | $0 | 1,875 | Apr 1, 2025 |
| Dec 14, 2024 | BTAIQ BioXcel Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +521 | - | - | 20,122 | Dec 17, 2024 |
| Dec 16, 2024 | BTAIQ BioXcel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -165 | $0.35 | $58 | 19,957 | Dec 17, 2024 |
| Dec 14, 2024 | BTAIQ BioXcel Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -521 | $0.00 | $0 | 2,606 | Dec 17, 2024 |
Questions about Vincent O'Neill
Answered from the filings on this page, as of the latest one.
Is Vincent O'Neill buying or selling?
Not in the last 12 months. Vincent O'Neill's latest open-market trade on SEC Form 4 was sold $58 of BTAIQ on Dec 16, 2024.
How did Vincent O'Neill's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vincent O'Neill has 0.
Where does Vincent O'Neill file Form 4?
Vincent O'Neill has filed Form 4 at BTAIQ (BioXcel Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.